Habeo Cell Therapy (ECCS-50) - Cytori Therap
Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis (clinicaltrials.gov) - Aug 14, 2019 - P1; N=25; Recruiting; Sponsor: Mayo Clinic; Trial completion date: Dec 2018 ➔ Jun 2022; Trial primary completion date: Nov 2018 ➔ Jun 2020 
Clinical • Trial completion date • Trial primary completion date •
http://clinicaltrials.gov/ct2/show/NCT03269409
 
Aug 14, 2019
 
Prev Next